Evidence map›Paper›PMID 28243725›Full record

ArticleActa neuropathologica2017

Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.

Jelena Scekic-Zahirovic, Hajer El Oussini, Sina Mersmann, Kevin Drenner, Marina Wagner, Ying Sun, Kira Allmeroth, Stéphane Dieterlé, Jérôme Sinniger, Sylvie Dirrig-Grosch and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Acta neuropathologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 135 citations in OpenAlex.

  1. Autoimmune processes and production of catalytically active antibodies-abzymes in prone to amyotrophic lateral sclerosis FUS(1-359) mice.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. SLP2/PHB Aggregates in ALS Mouse Models and Patients: Implications BeyondInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 3 countries.

Jelena Scekic-ZahirovicInserm, UMR-S1118, 67085, Strasbourg, France.
Hajer El OussiniInserm, UMR-S1118, 67085, Strasbourg, France.
Sina MersmannMolecular Neurogenetics Laboratory, Max Planck Institute for Molecular Biomedicine, Muenster, Germany.
Kevin DrennerDepartment of Neurosciences, Ludwig Institute for Cancer Research, University of California, San Diego, USA.
Marina WagnerMolecular Neurogenetics Laboratory, Max Planck Institute for Molecular Biomedicine, Muenster, Germany.
Ying SunDepartment of Neurosciences, Ludwig Institute for Cancer Research, University of California, San Diego, USA.
Kira AllmerothMolecular Neurogenetics Laboratory, Max Planck Institute for Molecular Biomedicine, Muenster, Germany.
Stéphane DieterléInserm, UMR-S1118, 67085, Strasbourg, France.
Jérôme SinnigerInserm, UMR-S1118, 67085, Strasbourg, France.
Sylvie Dirrig-GroschInserm, UMR-S1118, 67085, Strasbourg, France.
Frédérique RenéInserm, UMR-S1118, 67085, Strasbourg, France.
Dorothee DormannBioMedical Center (BMC), Cell Biology, Ludwig-Maximilians-Universität München, Munich, Germany.
Christian HaassMunich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Albert C LudolphDepartment of Neurology, Ulm University, Ulm, Germany.
Clotilde Lagier-TourenneDepartment of Neurosciences, Ludwig Institute for Cancer Research, University of California, San Diego, USA.
Erik StorkebaumMolecular Neurogenetics Laboratory, Max Planck Institute for Molecular Biomedicine, Muenster, Germany. erik.storkebaum@mpi-muenster.mpg.de.
Luc DupuisInserm, UMR-S1118, 67085, Strasbourg, France. ldupuis@unistra.fr.
Inserm · FRMax Planck Institute for Molecular Biomedicine · DEUniversité de Strasbourg · FRLudwig Cancer Research · USBroad Institute · USGerman Center for Neurodegenerative Diseases · DELudwig-Maximilians-Universität München · DEUniversität Ulm · DEUniversity of Münster · DE

Funding

European Research Council 321366
6 · The paper itself

Abstract

Motor neuron-extrinsic mechanisms have been shown to participate in the pathogenesis of ALS-SOD1, one familial form of amyotrophic lateral sclerosis (ALS). It remains unclear whether such mechanisms contribute to other familial forms, such as TDP-43 and FUS-associated ALS. Here, we characterize a single-copy mouse model of ALS-FUS that conditionally expresses a disease-relevant truncating FUS mutant from the endogenous murine Fus gene. We show that these mice, but not mice heterozygous for a Fus null allele, develop similar pathology as ALS-FUS patients and a mild motor neuron phenotype. Most importantly, CRE-mediated rescue of the Fus mutation within motor neurons prevented degeneration of motor neuron cell bodies, but only delayed appearance of motor symptoms. Indeed, we observed downregulation of multiple myelin-related genes, and increased numbers of oligodendrocytes in the spinal cord supporting their contribution to behavioral deficits. In all, we show that mutant FUS triggers toxic events in both motor neurons and neighboring cells to elicit motor neuron disease.

Indexed as

Amyotrophic Lateral SclerosisAnimalsAxonsCytoplasmDisease Models, AnimalMaleMice, Inbred C57BLMice, TransgenicMotor ActivityMotor NeuronsMuscle, SkeletalMutationNerve DegenerationOligodendrogliaRNA-Binding Protein FUSRNA, MessengerFUS protein, mouseRNA-Binding Protein FUSRNA, MessengerAmyotrophic lateral sclerosisFronto-temporal dementiaMouse modelsNon-cell autonomous mechanismsRNA-binding proteins

Identifiers

PMID28243725
PMCPMC5427169
OpenAlexW2592954747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.